Protein Production Technology Podcast

Powered by Protein Production Technology International

Sports nutrition is no longer just about protein shakes and muscle building. Today's consumers are looking for products that support recovery, metabolic health, digestion, longevity, and overall wellness - creating new opportunities for ingredient innovation across the sector.

In this episode of the Protein Production Technology International podcast, Nick Bradley was joined by Winston Sun of Angel Yeast Europe, Chris Terry of Nutrabolt, Caroline Orfila Jenkins of Oatly, Adam Adamek of Impact Brussels, Edoardo Imparato of Small Giants, and Nick Morgan of Nutrition Integrated to explore how the sports nutrition market is evolving and what that means for the future of protein innovation.

The panel discussed the growing demand for alternative protein sources, including fermentation-derived, microbial, and plant-based ingredients, alongside the ongoing dominance of whey protein. The conversation examined how rising ingredient costs, sustainability pressures, and changing consumer expectations are driving brands to rethink traditional formulation strategies.

The speakers also explored the challenges of developing products that deliver on taste, texture, functionality, affordability, and nutritional performance simultaneously. Topics included hybrid protein formulations, amino acid quality, consumer trust, clean-label demands, and the growing role of evidence-backed ingredients in an increasingly competitive marketplace.

As sports nutrition continues to move beyond elite athletes and into mainstream health and wellness, the discussion highlighted how emerging technologies and diversified protein sources are expanding opportunities for product developers and brands alike.

A must-listen for sports nutrition brands, ingredient suppliers, product developers, food scientists, investors, and anyone interested in the future of protein innovation and active lifestyle nutrition.

Powered by Protein Production Technology International

Should food and fermentation companies build their own manufacturing capabilities - or can the right partners get them to market faster and more efficiently?

In this episode of the Protein Production Technology International podcast, Nick Bradley was joined by Ariel Blumovich of YD Labs, David Ziskind of Mach Global Advisors, Tzvi Zvirin of BioArmix, Arnon Heyman of IBI Ag, and Ori Zakin of BioRaptor.AI to explore the evolving role of CDMOs in food and biotechnology scale-up.

The panel challenged the perception that contract development and manufacturing organizations are simply outsourced service providers, discussing how strategic partnerships can help companies accelerate development, reduce capital requirements, and access expertise that would be difficult to build internally.

The conversation examined one of the most important questions facing growth-stage companies: what should be built in-house and what should be entrusted to external partners? Speakers shared practical insights into protecting intellectual property, structuring long-term collaborations, and creating governance frameworks that allow innovation to flourish without compromising competitive advantage.

Drawing on real-world experiences from across the food tech and biotechnology sectors, the discussion also explored why some CDMO relationships thrive while others fail, highlighting the importance of trust, transparency, aligned incentives, and continuous collaboration.

From manufacturing strategy and partnership models to investment considerations and scale-up planning, the episode offered a practical framework for companies seeking to grow without overbuilding infrastructure too early.

A must-listen for founders, R&D leaders, operations teams, investors, and anyone navigating the complex decisions required to scale food and fermentation technologies successfully.

Powered by Protein Production Technology International

A breakthrough ingredient or production process may create headlines, but can it create a defensible business?

In this episode of the Protein Production Technology International podcast, Nick Bradley was joined by Kerry Rees and Andrew Tindall of HGF, alongside Gilbert Verschelling of The Protein Brewery, Tim Fronzek of Nosh.bio, and Casey Lippmeier of Checkerspot, to explore how alternative protein companies can build intellectual property strategies that support long-term commercial success.

The panel discussed why effective IP management extends far beyond filing patents, examining how founders can align protection strategies with business objectives, fundraising plans, partnerships, and commercialization roadmaps. The conversation explored the balance between patents and trade secrets, the risks of over-filing, and how companies can ensure their most valuable innovations remain protected as they scale.

The speakers also shared insights into what investors look for when assessing technology businesses, explaining why strong IP portfolios can strengthen a company's position but are rarely enough on their own. Market traction, execution capability, regulatory progress, and commercial readiness all play critical roles in building investor confidence.

From collaboration agreements and freedom-to-operate considerations to licensing strategies and enforcement, the discussion offered practical guidance for founders navigating one of the most important - and often misunderstood - aspects of building an alternative protein company.

A must-listen for founders, R&D leaders, investors, legal teams, and anyone seeking to transform innovation into a scalable and defensible business.

Powered by Protein Production Technology International

What does it take for a biotechnology company to evolve from a promising startup into a commercially focused nutrition business?

In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with John Krzywicki, CEO of Checkerspot, to discuss the company's journey from developing industrial materials to commercializing high-value nutritional ingredients derived from microalgae.

Krzywicki shared how Checkerspot is using heterotrophic microalgae and precision fermentation to produce specialty fats and oils, including ingredients designed to replicate those found naturally in human breast milk. The conversation explored why microalgae offers unique advantages as a production platform and how advances in biotechnology are opening new opportunities in infant nutrition and broader health applications.

The discussion also provided a candid look at the realities of scale-up, including resource allocation, capital efficiency, and the strategic decisions required to focus on the most commercially attractive opportunities. Krzywicki explained why partnerships have played a critical role in the company's growth and how Checkerspot's licensing-led approach is designed to accelerate adoption while minimizing capital requirements.

From ingredient innovation and commercialization to manufacturing strategy and market focus, the episode highlighted the challenges and opportunities facing biotechnology companies as they transition from technology development to sustainable business growth.

A must-listen for fermentation companies, ingredient developers, nutrition brands, investors, and anyone interested in the commercialization of next-generation food ingredients.

Powered by Protein Production Technology International

Why do so many promising biotechnology breakthroughs fail to reach commercial scale?

In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Thomas G. Schmidt, CEO of 21st.BIO, to discuss one of the industry's biggest challenges: bridging the 'Valley of Death' between laboratory success and industrial-scale production.

Drawing on the company's roots within the Novo Group ecosystem, Schmidt explained how 21st.BIO is helping startups accelerate commercialization by providing access to proven technology platforms, industrial expertise, and large-scale production capabilities. The conversation explored why scientific innovation alone is rarely enough and why companies must demonstrate credible pathways to manufacturing at scale.

Schmidt also shared his perspective on the future economics of precision fermentation, including why achieving competitive production costs, improving titers, and maximizing carbon conversion efficiency will be critical to long-term success. The discussion examined 21st.BIO's work with beta-lactoglobulin (BLG), the importance of moving beyond sustainability-focused narratives, and the need to build businesses that can compete on performance and economics.

The episode also looked at how biotechnology can evolve from replicating existing proteins to creating entirely new nutritional possibilities, unlocking greater efficiency and helping meet growing global demand for protein.

From scale-up and manufacturing to investment, partnerships, and the future of precision fermentation, this conversation offered valuable insights into what it will take to transform breakthrough science into commercially viable food production.

A must-listen for fermentation companies, investors, food manufacturers, technology developers, and anyone interested in the realities of scaling the next generation of protein production.

Powered by Protein Production Technology International

Can dairy proteins be produced without cows while still delivering the taste, texture, and functionality consumers expect?

In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Yvan Chardonnens, CEO of Standing Ovation, to discuss how precision fermentation is being used to produce animal-free casein and what that could mean for the future of dairy.

Chardonnens explained why casein remains one of the most challenging and important dairy proteins to replicate, particularly for applications such as cheese, where melt, stretch, and texture are critical. The conversation explored Standing Ovation's approach to producing casein through fermentation, as well as the company's broader ambition to help address growing global protein demand.

A key focus of the discussion was Standing Ovation's circular economy model, which utilizes dairy industry side streams such as acid whey as fermentation feedstocks. Chardonnens shared how this approach can reduce production costs while creating new value streams for dairy processors, demonstrating how traditional and emerging food technologies can work together.

The episode also examined partnerships with major dairy companies, progress toward regulatory approval in the USA, and the potential role of hybrid dairy products in introducing fermentation-derived proteins to consumers.

From food sovereignty and sustainability to commercialization and consumer acceptance, this conversation offered a detailed look at how precision fermentation could help reshape the future of dairy production.

A must-listen for dairy companies, food manufacturers, fermentation innovators, investors, and anyone interested in the next generation of functional proteins.

Powered by Protein Production Technology International

What if cultivated meat's first commercial breakthrough comes through pet food rather than human food?

In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Joshua Errett, Founder and CEO of Friends & Family Pet Food Company, to discuss the launch of cultivated pet food in Singapore and why he believes the category could become one of the most important early markets for cultivated proteins.

Drawing on more than a decade in the alternative protein sector, Errett shared his perspective on the industry's evolution and explained why he views cultivated meat as an entirely new ingredient platform rather than simply an alternative to conventional meat. The conversation explored changing consumer expectations around pet nutrition, the growing shift away from highly processed kibble, and the opportunity to deliver fresher, higher-quality ingredients for companion animals.

Errett also discussed the limitations of traditional rendering processes, the importance of preserving protein quality and essential amino acids, and why communicating clear nutritional benefits matters more than focusing on the technical details behind production.

From commercialization and consumer acceptance to sustainability and animal health, the discussion offered a fascinating look at how cultivated proteins could reshape one of the world's largest and fastest-growing pet food markets.

A must-listen for pet food manufacturers, cultivated meat companies, investors, and anyone interested in where alternative proteins may achieve their next major commercial milestone.

Powered by Protein Production Technology International

How do you tell the story of an industry that is constantly reinventing itself?

In this episode of the Protein Production Technology International podcast, Nick Bradley sat down with Alex Crisp, founder and host of the Future Foods Podcast, to discuss the evolution of alternative protein storytelling and the role media plays in shaping public understanding of food innovation.

Drawing on an unconventional background spanning law, teaching, and amateur dramatics, Crisp reflected on his journey from curious industry newcomer to one of the sector's most recognizable podcast hosts. The conversation explored how alternative protein narratives have matured, why transparency and authenticity matter more than ever, and how communicators can bridge the gap between complex science and mainstream audiences.

The discussion also examined the industry's expanding focus beyond cultivated meat, including growing interest in mycelium, fermentation, and broader sustainable food solutions. Throughout the episode, Crisp shared his perspective on building trust, avoiding hype, and creating meaningful conversations that resonate with both industry insiders and the wider public.

A must-listen for founders, researchers, communicators, investors, and anyone interested in how the future of food is being explained, debated, and understood.

Powered by Protein Production Technology International

What happens when alternative protein developers stop asking whether products should be plant-based or meat-based and start combining the best of both worlds?

In this episode of the Protein Production Technology International podcast, Caroline Cotto of NECTAR, Mylène Potier of Gira, Marc Renauld of Roquette, and Marion Lefebvre of Roquette explored why hybrid meat is emerging as one of the most commercially compelling opportunities in food innovation.

The discussion examined how combining complementary protein sources can help overcome some of the industry's biggest formulation challenges, including taste, texture, structure, nutrition, and affordability. The panel also shared insights into how hybrid approaches can improve product performance while helping manufacturers navigate cost pressures and scale production more effectively.

From ingredient functionality and consumer acceptance to real-world product development strategies, the conversation highlighted why hybrid meat is increasingly being viewed not as a compromise, but as a practical route to bringing better products to market.

A must-listen for product developers, ingredient suppliers, food manufacturers, retailers, and anyone interested in the next phase of alternative protein innovation.

Powered by Protein Production Technology International

Building a successful fermentation company is one thing. Financing a commercial-scale facility is another entirely.

In this episode of the Protein Production Technology International podcast, Diana Rucinschi of the European Innovation Fund, David Ziskind of Mach Global Advisors, Aakriti Mehta of Channel Capital Advisors, and Spencer White of Unibio joined host Nick Bradley to tackle one of the industry's biggest challenges: bridging the capital gap between pilot success and industrial deployment.

The panel explored why venture capital alone cannot fund the next generation of fermentation infrastructure, what lenders and project financiers need to see before committing capital, and how companies can combine equity, debt, strategic partnerships, offtake agreements, and public-private funding to unlock growth.

From becoming genuinely 'finance-ready' to reducing risk for investors and infrastructure partners, the discussion offered a practical look at how fermentation companies can move beyond promising technology and into commercial-scale manufacturing.

A must-listen for founders, investors, CFOs, and anyone involved in scaling fermentation from demonstration to industrial reality.